Hikma Pharmaceuticals USA Inc.

Hikma Pharmaceuticals USA Inc. phenobarbital sodium

In the graph: all 4 documents (15 pages).

Application: NDA 219357
Ticker: Hikma Pharmaceuticals USA Inc.
Product: phenobarbital sodium
Disease area: Not yet classified
Response path: Not yet classified
Complete Response Letters: December 23, 2024 · October 21, 2024 · January 23, 2024 · February 28, 2020

From FDA letters and SEC filings. Not investment or medical advice.

Group by

Build queue · replay at pipeline speed